Hepatitis C virus infection in special groups

F Zoulim1

  • 1Hôtel Dieu Hospital, and Hepatitis Research Unit INSERM 271, Lyon, France. zoulim@lyon151.inserm.fr

Journal of Hepatology
|January 6, 2000
PubMed

Insights

Hepatitis C virus (HCV) infection presents complex challenges, particularly in immunocompromised patients. Protecting at-risk individuals through universal precautions is crucial due to limited treatment efficacy.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection exhibits diverse clinical presentations.
  • HCV poses diagnostic and management challenges in specific patient groups like those on hemodialysis or with organ transplants.
  • Co-infection with Hepatitis B virus (HBV) can exacerbate liver disease severity.

Purpose of the Study:

  • To review the multifaceted clinical implications of HCV infection.
  • To highlight diagnostic and therapeutic complexities in vulnerable populations.
  • To emphasize the importance of preventive strategies.

Main Methods:

  • Literature review of clinical manifestations and outcomes of HCV infection.
  • Analysis of challenges in diagnostic assay selection.
  • Evaluation of treatment efficacy in special patient cohorts.

Main Results:

  • HCV infection impacts diagnostic choices, clinical course, and disease severity.
  • Outcomes in organ transplant recipients remain poorly understood.
  • Current antiviral therapies show limited effectiveness in high-risk groups.

Conclusions:

  • Universal precautionary measures are essential for preventing HCV transmission.
  • Further research is needed to understand long-term HCV consequences in immunocompromised patients.
  • Improved preventive strategies are vital given therapeutic limitations.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...